Interleukin-6 as prognosticator in patients with COVID-19

被引：139
|
作者：
Grifoni, Elisa [1 ]
Valoriani, Alice [2 ]
Cei, Francesco [2 ]
Lamanna, Roberta [3 ]
Gelli, Anna Maria Grazia [3 ]
Ciambotti, Benedetta [3 ]
Vannucchi, Vieri [4 ]
Moroni, Federico [4 ]
Pelagatti, Lorenzo [4 ]
Tarquini, Roberto [2 ]
Landini, Giancarlo [3 ]
Vanni, Simone [5 ]
Masotti, Luca [1 ]
机构：
[1] San Giuseppe Hosp, Internal Med 2, Viale Boccaccio 20, I-50053 Florence, Italy
[2] San Giuseppe Hosp, Internal Med 1, Empoli, Italy
[3] San Giuseppe Hosp, Clin Pathol, Lab Dept, Empoli, Italy
[4] Santa Maria Nuova Hosp, Internal Med, Florence, Italy
[5] San Giuseppe Hosp, Emergency Dept, Empoli, Italy
来源：
JOURNAL OF INFECTION | 2020年 / 81卷 / 03期
关键词：
D O I：
10.1016/j.jinf.2020.06.008
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：466 / 467
页数：2
相关论文
共 50 条
  • [21] COVID-19 and Cholestasis: Potential Role of Interleukin-6
    Satiya, Jinendra
    Lenik, Joanna M.
    Bergasa, Nora V.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S1267 - S1267
  • [22] Aldosterone and interleukin-6: the synergic effect in COVID-19
    Campana, Pasquale
    Palaia, Maria Emiliana
    Conte, Maddalena
    Petraglia, Laura
    Ferrante, Lorenzo
    Dario, Leosco
    Parisi, Valentina
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)
  • [23] Interleukin-6 (IL-6) as a Predictor of Clinical Outcomes in Patients with COVID-19
    Mahmood, Saad B. Z.
    Majid, Hafsa
    Arshad, Ainan
    Zaib-Un-Nisa, Noureen
    Niazali, Noureen
    Kazi, Kulsum
    Aslam, Aashir
    Ahmed, Sibtain
    Jamil, Bushra
    Jafri, Lena
    CLINICAL LABORATORY, 2023, 69 (06) : 1126 - 1133
  • [24] Criteria for the optimal use of interleukin-6 receptor blockers in patients with COVID-19
    Kruglova, Tatyana S.
    Fomina, Darya S.
    Poteshkina, Nataliya G.
    Frolova, Nadija F.
    Beloglazova, Irina P.
    Mutovina, Zinaida Yu
    Samsonova, Inna, V
    Kovalevskaja, Elena A.
    Zagrebneva, Alena, I
    Serdotetckova, Sofya A.
    Chernov, Anton A.
    Lysenko, Maryana A.
    TERAPEVTICHESKII ARKHIV, 2021, 93 (11) : 1316 - 1324
  • [25] Role of Interleukin-6 in Lung Complications in Patients With COVID-19: Therapeutic Implications
    Smetana, Karel, Jr.
    Brabek, Jan
    IN VIVO, 2020, 34 : 1589 - 1592
  • [26] Dynamic Interleukin-6 Level Changes as a Prognostic Indicator in Patients With COVID-19
    Liu, Zeming
    Li, Jinpeng
    Chen, Danyang
    Gao, Rongfen
    Zeng, Wen
    Chen, Sichao
    Huang, Yihui
    Huang, Jianglong
    Long, Wei
    Li, Man
    Guo, Liang
    Wang, Xinghuan
    Wu, Xiaohui
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [27] Evaluation of Interleukin-6 and its Association with the Severity of Disease in COVID-19 Patients
    Bhandari, Sudhir
    Rankawat, Govind
    Singh, Ajeet
    Wadhwani, Dileep
    Patel, Bhoopendra
    INDIAN JOURNAL OF MEDICAL SPECIALITIES, 2020, 11 (03) : 132 - 136
  • [28] Interleukin-6 and other cytokine blockade in COVID-19 hyperinflammation
    Gupta, Latika
    Agarwal, Vikas
    Ramanan, Athimalaipet, V
    INDIAN JOURNAL OF RHEUMATOLOGY, 2020, 15 (02) : 65 - 69
  • [29] Effects of Vitamin D and K on Interleukin-6 in COVID-19
    Visser, Margot P. J.
    Dofferhoff, Anton S. M.
    van den Ouweland, Jody M. W.
    van Daal, Henny
    Kramers, Cornelis
    Schurgers, Leon J.
    Janssen, Rob
    Walk, Jona
    FRONTIERS IN NUTRITION, 2022, 8
  • [30] Interleukin-6: Molecule in the Intersection of Cancer, Ageing and COVID-19
    Brabek, Jan
    Jakubek, Milan
    Vellieux, Frederic
    Novotny, Jiri
    Kolar, Michal
    Lacina, Lukas
    Szabo, Pavol
    Strnadova, Karolina
    Rosel, Daniel
    Dvorankova, Barbora
    Smetana, Karel, Jr.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (21) : 1 - 25
12345